Mardi Parham, Kargar Reza, Fazeli Ramina, Qorbani Mostafa
Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran.
Front Nutr. 2023 Feb 2;10:1059106. doi: 10.3389/fnut.2023.1059106. eCollection 2023.
Non-alcoholic fatty liver disease (NAFLD) results from an excessive accumulation of fat particles that causes liver inflammation, which ultimately causes liver damage. There is still considerable uncertainty about the effects of any nutritional supplements compared to no additional intervention. This review aimed to evaluate the efficacy of , known as garlic, in preventing and treating NAFLD.
A systematic search based on a search strategy consisting of two components of "NAFLD" and "" in databases including PubMed, Web of Science (WoS), and SCOPUS was conducted on papers evaluating the effects of on NAFLD treatment and prevention. We obtained studies from inception until 20 September 2022, followed by study selection and data extraction based on our eligibility criteria. Consequently, qualitative and quantitative synthesis was conducted.
Our qualitative analysis reveals that consumption is linked to the prevention of NAFLD, especially in males, although qualitative data in this study regarding the therapeutic properties of NAFLD was controversial. Our meta-analysis showed that NAFLD patients treated with have significantly declined aminotransferase levels. That is to say, our meta-analysis revealed a lower alanine transaminase (ALT) (SMD = -0.580, 95%CI = -0.822 to -0.338), and aspartate transaminase (AST(SMD = -0.526, 95%CI = -0.767 to -0.284) in NAFLD patients treated with compared to the placebo group. Also, pooling data from case-control studies showed that A. sativum consumption decreases the odds of being diagnosed with NAFLD by 46% (OR = 0.538, 95%CI = 0.451-0.625).
consumption is not merely associated with NAFLD prevention but also results in a considerable decline in blood aminotransferase levels in patients diagnosed with NAFLD. To put it simply, is linked to a decline in AST and ALT, which are considered reliable biomarkers of NAFLD response to treatment. Nevertheless, is insufficient to improve NAFLD independent of other dietary amendments and lifestyle modifications.
非酒精性脂肪性肝病(NAFLD)是由脂肪颗粒过度积累导致肝脏炎症,最终造成肝损伤引起的。与不进行额外干预相比,任何营养补充剂的效果仍存在相当大的不确定性。本综述旨在评估大蒜在预防和治疗NAFLD方面的功效。
在包括PubMed、科学网(WoS)和Scopus在内的数据库中,基于由“NAFLD”和“大蒜”两个部分组成的检索策略进行系统检索,以查找评估大蒜对NAFLD治疗和预防效果的论文。我们获取了从起始到2022年9月20日的研究,随后根据我们的纳入标准进行研究筛选和数据提取。因此,进行了定性和定量综合分析。
我们的定性分析表明,食用大蒜与预防NAFLD有关,尤其是在男性中,尽管本研究中关于NAFLD治疗特性的定性数据存在争议。我们的荟萃分析表明,接受大蒜治疗的NAFLD患者转氨酶水平显著下降。也就是说,我们的荟萃分析显示,与安慰剂组相比,接受大蒜治疗的NAFLD患者丙氨酸转氨酶(ALT)水平更低(标准化均数差[SMD]=-0.580,95%置信区间[CI]=-0.822至-0.338),天冬氨酸转氨酶(AST)水平更低(SMD=-0.526,95%CI=-0.767至-0.284)。此外,汇总病例对照研究的数据显示,食用大蒜使被诊断为NAFLD的几率降低了46%(比值比[OR]=0.538,95%CI=0.451-0.625)。
食用大蒜不仅与预防NAFLD有关,还会使被诊断为NAFLD的患者血液转氨酶水平显著下降。简单地说,大蒜与AST和ALT水平下降有关,而AST和ALT被认为是NAFLD治疗反应的可靠生物标志物。然而,大蒜不足以独立于其他饮食调整和生活方式改变来改善NAFLD。